Serotonin: Imaging Findings in Eating Disorders

Chapter
Part of the Current Topics in Behavioral Neurosciences book series (CTBN, volume 6)

Abstract

Anorexia nervosa (AN) and bulimia nervosa (BN) are disorders characterized by aberrant patterns of feeding behavior, weight regulation, and disturbances in attitudes and perceptions toward body weight and shape. Several lines of evidence nominate disturbances of serotonin (5-HT) pathways as playing a role in the pathogenesis and pathophysiology of AN and BN. For example, 5-HT pathways are known to contribute to the modulation of a range of behaviors commonly seen in individuals with AN and BN. New technology using brain imaging with radioligands offers the potential for understanding previously inaccessible brain 5-HT neurotransmitter function and its dynamic relationship with human behaviors. Recent studies using positron emission tomography and single photon emission computed tomography with 5-HT-specific radioligands have consistently shown 5-HT1A and 5-HT2A receptor and 5-HT transporter alterations in AN and BN in cortical and limbic structures, which may be related to anxiety, behavioral inhibition, and body image distortions. These disturbances are present when subjects are ill and persist after recovery, suggesting that these may be traits that are independent of the state of the illness. Effective treatments for AN and BN have been elusive. A better understanding of neurobiology is likely to be important for developing specific and more powerful therapies for these often chronic and deadly disorders.

Keywords

Anorexia nervosa Bulimia nervosa Serotonin Receptor Transporter Brain imaging PET SPECT 

References

  1. Amargos-Bosch M, Bortolozzi A, Puig MJS, Adell A, Celada P, Toth M, Mengod G, Artigas F (2004) Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex. Cerebral Cortex 14:281–299Google Scholar
  2. Anderluh MB, Tchanturia K, Rabe-Hesketh S, Treasure J (2003) Childhood obsessive-compulsive personality traits in adult women with eating disorders: defining a broader eating disorder phenotype. Am J Psychiatry 160:242–247PubMedCrossRefGoogle Scholar
  3. Anderson IM, Parry-Billings M, Newsholme EA, Fairburn CG, Cowen PJ (1990) Dieting reduces plasma tryptophan and alters brain 5-HT function in women. Psychol Med 20:785–91PubMedCrossRefGoogle Scholar
  4. Arango V, Underwood MD, Gubbi AV, Mann JJ (1995) Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res 688:121–33PubMedCrossRefGoogle Scholar
  5. Attia E, Schroeder L (2005) Pharmacologic treatment of anorexia nervosa: where do we go from here? Int J Eat Disord 37:S60–S63; discussion S87–S89Google Scholar
  6. Attia E, Wolk S, Cooper T, Glasofer D, Walsh B (2005) Plasma tryptophan during weight restoration in patients with anorexia nervosa. Biol Psychiatry 57:674–678PubMedCrossRefGoogle Scholar
  7. Audenaert K, Van Laere K, Dumont F, Vervaet M, Goethals I, Slegers G, Mertens J, Van Heeringen C, Dierckx R (2003) Decreased 5-HT2a receptor binding in patients with anorexia nervosa. J Nucl Med 44:163–169PubMedGoogle Scholar
  8. Bailer UF, Price JC, Meltzer CC, Mathis CA, Frank GK, Weissfeld L, Mcconaha CW, Henry SE, Brooks-Achenbach S, Barbarich NC, Kaye WH (2004) Altered 5-HT2A receptor binding after recovery from bulimia-type anorexia nervosa: relationships to harm avoidance and drive for thinness. Neuropsychopharmacology 29:1143–1155PubMedCrossRefGoogle Scholar
  9. Bailer UF, Frank GK, Henry SE, Price JC, Meltzer CC, Weissfeld L, Mathis CA, Drevets WC, Wagner A, Hoge J, Ziolko SK, Mcconana CW, Kaye WH (2005) Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [11C]WAY100635. Arch Gen Psychiatry 62:1032–1041PubMedCrossRefGoogle Scholar
  10. Bailer UF, Frank G, Henry S, Price J, Meltzer C, Mathis C, Wagner A, Thornton L, Hoge J, Ziolko SK, Becker C, Mcconaha C, Kaye WH (2007a) Exaggerated 5-HT1A but normal 5-HT2A receptor activity in individuals ill with anorexia nervosa. Biol Psychiatry 61:1090–1099PubMedCrossRefGoogle Scholar
  11. Bailer UF, Frank G, Henry S, Price J, Meltzer CC, Becker C, Ziolko SK, Mathis C, Wagner A, Barbarich-Marsteller N, Putman K, Kaye WH (2007b) Serotonin transporter binding after recovery from eating disorders. Psychopharmacology 195:315–324PubMedCrossRefGoogle Scholar
  12. Bailer U, Bloss C, Frank G, Price J, Meltzer C, Mathis C, Geyer M, Wagner A, Becker C, Schork N, Kaye W (2010) 5-HT1A receptor binding is increased after recovery from bulimia nervosa compared to control women and is associated with behavioral inhibition in both groups Int J Eat Disord (in press)Google Scholar
  13. Barr LC, Goodman WK, Price LH, Mcdougle CJ, Charney DS (1992) The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studies. J Clin Psychiatry 53(Suppl):17–28PubMedGoogle Scholar
  14. Berrettini W (2000) Genetics of psychiatric disease. Annu Rev Med 51:465–479PubMedCrossRefGoogle Scholar
  15. Blier P, De Montigny C (1999) Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders. Neuropsychopharmacology 21:91S–98SPubMedGoogle Scholar
  16. Blundell JE (1984) Serotonin and appetite. Neuropharmacology 23:1537–51PubMedCrossRefGoogle Scholar
  17. Bonhomme N, Esposito E (1998) Involvement of serotonin and dopamine in the mechanism of action of novel antidepressant drugs: a review. J Clin Psychopharmacol 18:447–454PubMedCrossRefGoogle Scholar
  18. Brewerton TD (1995) Toward a unified theory of serotonin dysregulation in eating and related disorders. Psychoneuroendocrinology 20:561–90PubMedCrossRefGoogle Scholar
  19. Brewerton TD, Hand LD, Bishop ER Jr (1993) The tridimensional personality questionnaire in eating disorder patients. Int J Eat Disord 14:213–218PubMedCrossRefGoogle Scholar
  20. Bulik CM, Sullivan PF, Joyce PR, Carter FA (1995) Temperament, character, and personality disorder in bulimia nervosa. J Nerv Ment Dis 183:593–8PubMedCrossRefGoogle Scholar
  21. Bulik CM, Sullivan PF, Fear JL, Joyce PR (1997) Eating disorders and antecedent anxiety disorders: a controlled study. Acta Psychiatr Scand 96:101–7PubMedCrossRefGoogle Scholar
  22. Bulik C, Sullivan PF, Tozzi F, Furberg H, Lichtenstein P, Pedersen NL (2006) Prevalence, heritability and prospective risk factors for anorexia nervosa. Arch Gen Psychiatry 63:305–312PubMedCrossRefGoogle Scholar
  23. Bulik C, Hebebrand J, Keski-Rahkonen A, Klump K, Reichborn-Kjennerud KS, Mazzeo S, Wade T (2007) Genetic epidemiology, endophenotypes, and eating disorder classification. Int J Eat Disord Suppl:S52–S60Google Scholar
  24. Burnet PW, Eastwood SL, Harrison PJ (1997) [3H]WAY-100635 for 5-HT1A receptor autoradiography in human brain: a comparison with [3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia. Neurochem Int 30:565–74PubMedCrossRefGoogle Scholar
  25. Bush G, Frazier JA, Rauch SL, Seidman LJ, Whalen PJ, Jenike MA, Rosen BR, Biederman J (1999) Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the Counting Stroop. Biol Psychiatry 45:1542–1552PubMedCrossRefGoogle Scholar
  26. Cervo L, Mocaer E, Bertaglia A, Samanin R (2000) Roles of 5-HT1A receptors in the dorsal raphe and dorsal hippocampus in anxiety assessed by the behavioral effects of 8-OH-DPAT and S 15535 in a modified Geller-Seifter conflict model. Neuropharmacology 39:1037–43PubMedCrossRefGoogle Scholar
  27. Charney DS, Deutch A (1996) A functional neuroanatomy of anxiety and fear: implications for the pathophysiology and treatment of anxiety disorders. Crit Rev Neurobiol 10:419–46PubMedGoogle Scholar
  28. Cleare A, Bond AJ (2000) Ipaspirone challenge in aggressive men shows an inverse correlation between 5HT1A receptor function and aggression. Psychopharmacology (Berl) 148:344Google Scholar
  29. Cloninger CR (1987) A systematic method for clinical description and classification of personality variants. A proposal. Arch Gen Psychiatry 44:573–88PubMedGoogle Scholar
  30. Cloninger CR, Przybeck TR, Svrakic DM, Wetzel RD (1994) The temperament and character inventory (TCI): a guide to its development and use. Center for Psychobiology of Personality, Washington University, St. Louis, MO, USAGoogle Scholar
  31. Coccaro EF, Gabriel S, Siever LJ (1990) Buspirone challenge: preliminary evidence for a role of 5HT1A receptors in behavioral irritability in personality disorderd patients. Psychopharmacol Bull 26:285Google Scholar
  32. Cooper SJ (1996) Cholecystokinin modulation of serotonergic control of feeding behavior. Ann NY Acad Sci 780:213–222PubMedCrossRefGoogle Scholar
  33. Critchley M (1953) The parietal lobes. Hafner, New YorkGoogle Scholar
  34. De Vry J, Schreiber R (2000) Effects of selected serotonin 5-HT(1) and 5-HT(2) receptor agonists on feeding behavior: possible mechanisms of action. Neurosci Biobehav Rev 24:341–53PubMedCrossRefGoogle Scholar
  35. Deep AL, Nagy LM, Weltzin TE, Rao R, Kaye WH (1995) Premorbid onset of psychopathology in long-term recovered anorexia nervosa. Int J Eat Disord 17:291–297PubMedGoogle Scholar
  36. Devinsky O, Morrell MJ, Vogt BA (1995) Contributions of anterior cingulate cortex to behaviour. Brain 118:279–306PubMedCrossRefGoogle Scholar
  37. Drevets W, Thase M, Moses-Kolko E, Price J, Frank E, Kupfer D, Mathis C (2007) Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nucl Med Biol 34:865–877PubMedCrossRefGoogle Scholar
  38. Fairbanks L, Melega W, Jorgensen M, Kaplan J, Mcguire M (2001) Social impulsivity inversely associated with CSF 5-HIAA and fluoxetine exposure in vermet monkeys. Neuropschopharmacology 24:370–378CrossRefGoogle Scholar
  39. Favaro A, Caregaro L, Burlina AB, Santonastaso P (2000) Tryptophan levels, excessive exercise, and nutritional status in anorexia nervosa. Psychosom Med 62:535–8PubMedGoogle Scholar
  40. Fernstrom JD, Wurtman RJ (1972) Brain serotonin content: physiological regulation by plasma neutral amino acids. Science 178:414–6PubMedCrossRefGoogle Scholar
  41. File SE, Kenny PJ, Cheeta S (2000) The role of the dorsal hippocampal serotonergic and cholinergic systems in the modulation of anxiety. Pharmacol Biochem Behav 66:65–72PubMedCrossRefGoogle Scholar
  42. Fisher P, Meltzer C, Ziolko S, Price J, Hariri AR (2007) Capacity for 5-HT1A-mediated autoregulation predicts amygdala reactivity. Nat Neurosci 9:1362–1363CrossRefGoogle Scholar
  43. Fluoxetine Bulimia Nervosa Collaborative Study Group (1992) Fluoxetine in the treatment of bulimia nervosa. A multicenter, placebo-controlled, double-blind trial. Arch Gen Psychiatry 49:139–147Google Scholar
  44. Frank GK, Kaye WH, Meltzer CC, Price JC, Greer P, Mcconaha C, Skovira K (2002) Reduced 5-HT2A receptor binding after recovery from anorexia nervosa. Biol Psychiatry 52:896–906PubMedCrossRefGoogle Scholar
  45. Frankle W, Lombardo I, New AS, Goodman M, Talbot P, Huang Y, Hwang D, Slifstein M, Curry S, Abi-Dargham A, Lauruelle M, Siever L (2005) Brain serotonin transporter distribution in subjects with impulsive aggressivity: a positron emission study with [11C]McN 5652. Am J Psychiatry 162:915–923PubMedCrossRefGoogle Scholar
  46. Galusca B, Costes N, Zito N, Peyron R, Bossu C, Lang F, Le Bars D, Estour B (2008) Organic background of restrictive-type anorexia nervosa suggested by increased serotonin(1A) receptor binding in right frontotemporal cortex of both lean and recovered patients: [(18)F]MPPF PET scan study. Biol Psychiatry 64:1009–1013PubMedCrossRefGoogle Scholar
  47. Garner DM (1991) The eating disorders inventory-2 manual. In: Psychological Assessment Resources. Psychological Assessment Resources, Odessa, FL, USAGoogle Scholar
  48. Geyer MA (1996) Serotonergic functions in arousal and motor activity. Behav Brain Res 73:31–35PubMedCrossRefGoogle Scholar
  49. Godart NT, Flament MF, Lecrubier Y, Jeammet P (2000) Anxiety disorders in anorexia nervosa and bulimia nervosa: co-morbidity and chronology of appearance. Eur Psychiatry 15:38–45PubMedCrossRefGoogle Scholar
  50. Godart NT, Flament MF, Perdereau F, Jeammet P (2002) Comorbidity between eating disorders and anxiety disorders: a review. Int J Eat Disord 32:253–270PubMedCrossRefGoogle Scholar
  51. Goethals I, Vervaet M, Audenaert K, Van De Wiele C, Ham H, Vandecapelle M, Slegers G, Dierckx RA, Van Heeringen C (2004) Comparison of cortical 5-HT2A receptor binding in bulimia nervosa patients and healthy volunteers. Am J Psychiatry 161:1916–1918PubMedCrossRefGoogle Scholar
  52. Goethals I, Vervaet M, Audenaert K, Jacobs F, Ham H, Van Heeringen C (2007) Does regional brain perfusion correlate with eating disorder symptoms in anorexia and bulimia nervosa. J Psychiatr Res 41:1005–1011PubMedCrossRefGoogle Scholar
  53. Grahame-Smith DG (1992) Serotonin in affective disorders. Int Clin Psychopharmacol 6(Suppl 4):5–13PubMedCrossRefGoogle Scholar
  54. Groenink L, Van Bogaert M, Van Der Gugten J, Oosting R (2003) 5-HT1A receptor and 5-HT1B receptor knockout mice in stress and anxiety paradigms. Behav Pharmacol 14:369–383PubMedGoogle Scholar
  55. Hajos M, Gartside SE, Varga V, Sharp T (2003) In vivo inhibition of neuronal activity in the rat ventromedial prefrontal cortex by midbrain-raphe nuclei: role of 5-HT1A receptors. Neuropharmacology 45:72–81PubMedCrossRefGoogle Scholar
  56. Hudson J, Hiripi E, Pope H, Kessler R (2007) The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry 61:348–358PubMedCrossRefGoogle Scholar
  57. Jimerson DC, Lesem MD, Hegg AP, Brewerton TD (1990) Serotonin in human eating disorders. Ann NY Acad Sci 600:532–44PubMedCrossRefGoogle Scholar
  58. Jimerson DC, Lesem MD, Kaye WH, Brewerton TD (1992) Low serotonin and dopamine metabolite concentrations in cerebrospinal fluid from bulimic patients with frequent binge episodes. Arch Gen Psychiatry 49:132–138PubMedGoogle Scholar
  59. Johnson P, Lightman S, Lowry C (2004) A functional subset of serotonergic neruons in the rat ventrolateral periaqueductal gray implicated in the inhibition of sympathoexcitation and panic. Ann NY Acad Sci 1018:58–64PubMedCrossRefGoogle Scholar
  60. Kaye WH, Weltzin TE (1991) Serotonin activity in anorexia and bulimia nervosa: relationship to the modulation of feeding and mood. J Clin Psychiatry 52(Suppl):41–48Google Scholar
  61. Kaye WH, Ebert MH, Raleigh M, Lake R (1984) Abnormalities in CNS monoamine metabolism in anorexia nervosa. Arch Gen Psychiatry 41:350–5PubMedGoogle Scholar
  62. Kaye WH, Gwirtsman HE, George DT, Jimerson DC, Ebert MH (1988) CSF 5-HIAA concentrations in anorexia nervosa: reduced values in underweight subjects normalize after weight gain. Biol Psychiatry 23:102–5PubMedCrossRefGoogle Scholar
  63. Kaye WH, Gwirtsman HE, George DT, Jimerson DC, Ebert MH, Lake CR (1990) Disturbances of noradrenergic systems in normal weight bulimia: relationship to diet and menses. Biol Psychiatry 27:4–21PubMedCrossRefGoogle Scholar
  64. Kaye WH, Gwirtsman HE, George DT, Ebert MH (1991a) Altered serotonin activity in anorexia nervosa after long-term weight restoration. Does elevated cerebrospinal fluid 5-hydroxyindoleacetic acid level correlate with rigid and obsessive behavior? Arch Gen Psychiatry 48:556–62PubMedGoogle Scholar
  65. Kaye WH, Weltzin TE, Hsu LK, Bulik CM (1991b) An open trial of fluoxetine in patients with anorexia nervosa. J Clin Psychiatry 52:464–71PubMedGoogle Scholar
  66. Kaye W, Gendall K, Strober M (1998a) Serotonin neuronal function and selective serotonin reuptake inhibitor treatment in anorexia and bulimia nervosa. Biol Psychiatry 44:825–38PubMedCrossRefGoogle Scholar
  67. Kaye WH, Greeno CG, Moss H, Fernstrom J, Fernstrom M, Lilenfeld LR, Weltzin TE, Mann JJ (1998b) Alterations in serotonin activity and psychiatric symptomatology after recovery from bulimia nervosa. Arch Gen Psychiatry 55:927–935PubMedCrossRefGoogle Scholar
  68. Kaye WH, Frank GK, Meltzer CC, Price JC, Mcconaha CW, Crossan PJ, Klump KL, Rhodes L (2001a) Altered serotonin 2A receptor activity in women who have recovered from bulimia nervosa. Am J Psychiatry 158:1152–1155PubMedCrossRefGoogle Scholar
  69. Kaye WH, Nagata T, Weltzin TE, Hsu LK, Sokol MS, Mcconaha C, Plotnicov KH, Weise J, Deep D (2001b) Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa. Biol Psychiatry 49:644–52PubMedCrossRefGoogle Scholar
  70. Kaye WH, Barbarich NC, Putnam K, Gendall KA, Fernstrom J, Fernstrom M, Mcconaha CW, Kishore A (2003) Anxiolytic effects of acute tryptophan depletion in anorexia nervosa. Int J Eat Disord 33:257–267PubMedCrossRefGoogle Scholar
  71. Kaye W, Bulik C, Thornton L, Barbarich N, Masters K, Fichter M, Halmi K, Kaplan A, Strober M, Woodside DB, Bergen A, Crow S, Mitchell J, Rotondo A, Mauri M, Cassano G, Keel PK, Plotnicov K, Pollice C, Klump K, Lilenfeld LR, Devlin B, Quadflieg R, Berrettini WH (2004) Comorbidity of anxiety disorders with anorexia and bulimia nervosa. Am J Psychiatry 161:2215–2221PubMedCrossRefGoogle Scholar
  72. Kaye W, Frank G, Bailer UF, Henry S, Meltzer CC, Price J, Mathis C, Wagner A (2005) Serotonin alterations in anorexia and bulimia nervosa: new insights from imaging studies. Physiol Behav 85:73–81PubMedCrossRefGoogle Scholar
  73. Kaye W, Strober M, Jimerson D (2008) The neurobiology of eating disorders. In: Charney D, Nestler E (eds) The neurobiology of mental illness, 3rd edn. Oxford Press, New YorkGoogle Scholar
  74. Kaye W, Fudge J, Paulus M (2009) New insight into symptoms and neurocircuit function of anorexia nervosa. Nat Rev Neurosci 10:573–584PubMedCrossRefGoogle Scholar
  75. Kendler KS, Maclean C, Neale M, Kessler R, Heath A, Eaves L (1991) The genetic epidemiology of bulimia nervosa. Am J Psychiatry 148:1627–37PubMedGoogle Scholar
  76. Kendler KS, Walters EE, Neale MC, Kessler RC, Heath AC, Eaves LJ (1995) The structure of the genetic and environmental risk factors for six major psychiatric disorders in women. Phobia, generalized anxiety disorder, panic disorder, bulimia, major depression, and alcoholism. Arch Gen Psychiatry 52:374–83PubMedGoogle Scholar
  77. Kingston K, Szmukler G, Andrewes D, Tress B, Desmond P (1996) Neuropsychological and structural brain changes in anorexia nervosa before and after refeeding. Psychol Med 26:15–28PubMedCrossRefGoogle Scholar
  78. Kleifield EI, Sunday S, Hurt S (1993) Psychometric validation of the Tridimensional Personality Questionnaire: application to subgroups of eating disorders. Compr Psychiatry 34:249–53PubMedCrossRefGoogle Scholar
  79. Klump KL, Bulik CM, Pollice C, Halmi KA, Fichter MM, Berrettini WH, Devlin B, Strober M, Kaplan A, Woodside DB, Treasure J, Shabbout M, Lilenfeld LR, Plotnicov KH, Kaye WH (2000) Temperament and character in women with anorexia nervosa. J Nerv Ment Dis 188:559–67PubMedCrossRefGoogle Scholar
  80. Koskela AK-R, Sihvola E, Kauppinen T, Kaprio JA, Rissanen A (2007) Serotonin transporter binding of [123I]ADAM in bulimic women, their healthy twin sisters, and healthy women: a SPET study. BMC Psychiatry 21:7–9Google Scholar
  81. Krebs-Thomson K, Geyer MA (1998) Evidence for a functional interaction between 5-HT1A and 5-HT2A receptors in rats. Psychopharmacology 140:69–74PubMedCrossRefGoogle Scholar
  82. Kuikka JT, Tammela L, Karhunen L, Rissanen A, Bergstrom KA, Naukkarinen H, Vanninen E, Karhu J, Lappalainen R, Repo-Tiihonen E, Tiihonen J, Uusitupa M (2001) Reduced serotonin transporter binding in binge eating women. Psychopharmacology 155:310–314PubMedCrossRefGoogle Scholar
  83. Lanfumey L, Hamon M (2000) Central 5-HT1A receptors: regional distribution and functional characteristics. Nucl Med Biol 27:429–435PubMedCrossRefGoogle Scholar
  84. Lanzenberger R, Mitterhauser M, Spindelegger C, Wadsak W, Klein N, Mien L, Holik A, Attarbaschi T, Mossaheb N, Sacher J, Geiss-Granadia T, Keletter K, Kasper S, Tauscher J (2007) Reduced serotonin-1A receptor binding in social anxiety disorder. Biol Psychiatry 61:1081–1089PubMedCrossRefGoogle Scholar
  85. Leibowitz SF, Shor-Posner G (1986) Brain serotonin and eating behavior. Appetite 7:1–14PubMedGoogle Scholar
  86. Lilenfeld LR, Kaye WH, Greeno CG, Merikangas KR, Plotnicov K, Pollice C, Rao R, Strober M, Bulik CM, Nagy L (1998) A controlled family study of anorexia nervosa and bulimia nervosa: psychiatric disorders in first-degree relatives and effects of proband comorbidity. Arch Gen Psychiatry 55:603–610PubMedCrossRefGoogle Scholar
  87. Lilenfeld L, Wonderlich S, Riso LP, Crosby R, Mitchell J (2006) Eating disorders and personality: a methodological and empirical review. Clin Psychol Rev 26:299–320PubMedCrossRefGoogle Scholar
  88. Mann JJ (1999) Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior. Neuropsychopharmacology 21:99S–105SPubMedGoogle Scholar
  89. Matsubara S, Arora RC, Meltzer HY (1991) Serotonergic measures in suicide brain: 5-HT1A binding sites in frontal cortex of suicide victims. J Neural Transm Gen Sect 85:181–94PubMedCrossRefGoogle Scholar
  90. Mesulam M (1981) A cortical network for directed attention and unilateral neglect. Ann Neurol 10:309–325PubMedCrossRefGoogle Scholar
  91. Miller JB, Ogden T, Oquendo M, Sullivan G, Mann J, Parsey R (2009) Elevated serotonin 1A binding in remitted major depressive disorder: evidence for a trait biological abnormality. Neuropsychopharmacology 34:2275–2284PubMedCrossRefGoogle Scholar
  92. Mitchell J, Crow S, Peterson CW, Crosby R (1998) Feeding laboratory studies in patients with eating disorders: A review. Int J Eat Disord 24:115–124PubMedCrossRefGoogle Scholar
  93. Nash J, Sargent P, Rabiner E, Hood SA, Potokar J, Grasby PN (2008) Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study. Br J Psychiatry 193:229–234PubMedCrossRefGoogle Scholar
  94. Neumeister A, Brain E, Nugent A, Carson R, Bonne O, Lucnekbaugh D, Eckelman W, Herschovitch P, Charney D, Drevets W (2004) Reduced serotinin type 1A receptor binding in panic disorder. J Neurosci 24:589–591PubMedCrossRefGoogle Scholar
  95. O'dwyer AM, Lucey JV, Russell GF (1996) Serotonin activity in anorexia nervosa after long-term weight restoration: response to D-fenfluramine challenge. Psychol Med 26:353–359PubMedCrossRefGoogle Scholar
  96. Olivier B, Pattij T, Wood S, Oosting R, Sarnyai Z, Toth M (2001) The 5-HT1A receptor knockout mouse and anxiety. Behav Pharmacol 12:439–450PubMedGoogle Scholar
  97. Petty F, Davis LL, Kabel D, Kramer GL (1996) Serotonin dysfunction disorders: a behavioral neurochemistry perspective. J Clin Psychiatry 57:11–6PubMedGoogle Scholar
  98. Romano SJ, Halmi KA, Sarkar NP, Koke SC, Lee JS (2002) A placebo-controlled study of fluoxetine in continued treatment of bulimia nervosa after successful acute fluoxetine treatment. Am J Psychiatry 159:96–102PubMedCrossRefGoogle Scholar
  99. Santana N, Bortolozzi A, Serrats J, Mengod G, Artigas F (2004) Expression of serotoinin1A and serotonin2A receptor in pyramidal and GABAergic neurons of the rat prefrontal cortex. Cereb Cortex 14:1100–1109PubMedCrossRefGoogle Scholar
  100. Saudou F, Hen R (1994) 5-Hydroxytryptamine receptor subtypes in vertebrates and invertebrates. Neurochem Int 25:503–32PubMedCrossRefGoogle Scholar
  101. Savitz J, Lucki I, Drevets W (2009) 5-HT(1A) receptor function in major depressive disorder. Prog Neurobiol 88:17–31PubMedCrossRefGoogle Scholar
  102. Schweiger U, Warnhoff M, Pahl J, Pirke KM (1986) Effects of carbohydrate and protein meals on plasma large neutral amino acids, glucose, and insulin plasma levels of anorectic patients. Metabolism 35:938–43PubMedCrossRefGoogle Scholar
  103. Silberg J, Bulik C (2005) Developmental association between eating disorders symptoms and symptoms of depression and anxiety in juvenile twin girls. J Child Psychol Psychiatr 46:1317–1326CrossRefGoogle Scholar
  104. Simansky KJ (1996) Serotonergic control of the organization of feeding and satiety. Behav Brain Res 73:37–42PubMedCrossRefGoogle Scholar
  105. Simansky K, Dave K, Inemer B, Nicklous D, Padron J, Aloyo V, Romano A (2004) A 5-HT2C agonist elicits hyperactivity and oral dyskinesia with hypophagia in rabbits. Physiol Behav 82:97–107PubMedCrossRefGoogle Scholar
  106. Soubrie P (1986) Reconciling the role of central serotonin neurons in human and animal behavior. Behav Brain Sci 9:319CrossRefGoogle Scholar
  107. Staley J, Malison R, Innis R (1998) Imaging of the serotonergic system: interactions of neuroanatomical and functional abnormalities of depression. Biol Psychiatry 44:534–549PubMedCrossRefGoogle Scholar
  108. Steiger H, Gauvin L, Israel M, Lkoerner N, Ng Ying Kin N, Paris J, Young SN (2001a) Association of serotonin and cortisol indices with childhood abuse in bulimia nervosa. Arch Gen Psychiatry 58:837–843PubMedCrossRefGoogle Scholar
  109. Steiger H, Koerner N, Engelberg MJ, Israel M, Ng Ying Kin NM, Young SN (2001b) Self-destructiveness and serotonin function in bulimia nervosa. Psychiatry Res 103:15–26PubMedCrossRefGoogle Scholar
  110. Steiger H, Young SN, Kin NM, Koerner N, Israel M, Lageix P, Paris J (2001c) Implications of impulsive and affective symptoms for serotonin function in bulimia nervosa. Psychol Med 31:85–95PubMedCrossRefGoogle Scholar
  111. Steiger H, Joober R, Israel M, Young S, Ng Ying Kin N, Gauvin L, Bruce K, Joncas J, Torkaman-Zehi A (2005a) The 5HTTLPR polymorphism, psychopathological symptoms, and platelet [3H-] paroxetine binding in bulimic syndromes. Int J Eat Disord 37:57–60PubMedCrossRefGoogle Scholar
  112. Steiger H, Richardson J, Israel M, Ng Ying Kin N, Bruce K, Mansour S, Marie Parent A (2005b) Reduced density of platelet-binding sites for [3H]paroxetine in remitted bulimic women. Neuropsychopharmacology 30:1028–1032PubMedCrossRefGoogle Scholar
  113. Steiger H, Richardson J, Joober R, Gauvin L, Israel M, Bruce K, Ying Kin N, Howard H, Young S (2007) The 5HTTLPR polymorphism, prior maltreatment and dramatic-erratic personality manifestations in women with blimic syndromes. J Psychiatr Res 32:354–362Google Scholar
  114. Stein DJ, Hollander E, Liebowitz MR (1993) Neurobiology of impulsivity and the impulse control disorders. J Neuropsychiatry Clin Neurosci 5:9–17PubMedGoogle Scholar
  115. Steinglass JE, Walsh T (2004) Psychopharmacology of anorexia nervosa, bulimia nervosa, and binge eating disorder. In: Brewerton TD (ed) Clinical handbook of eating disorders: an integrated approach. Marcel Dekker, New YorkGoogle Scholar
  116. Stice E (2002) Risk and maintenance factors for eating pathology: a meta-analytic review. Pychopharm Bull 128:825–848CrossRefGoogle Scholar
  117. Stockmeier CA (1997) Neurobiology of serotonin in depression and suicide. Ann NY Acad Sci 836:220–32PubMedCrossRefGoogle Scholar
  118. Strober M (1995) Family-genetic perspectives on anorexia nervosa and bulimia nervosa. In: Brownell K, Fairburn C (eds) Eating disorders and obesity-a comprehensive handbook. Guilford, New YorkGoogle Scholar
  119. Strober M, Freeman R, Morrell W (1997) The long-term course of severe anorexia nervosa in adolescents: survival analysis of recovery, relapse, and outcome predictors over 10–15 years in a prospective study. Int J Eat Disord 22:339–360PubMedCrossRefGoogle Scholar
  120. Strober M, Freeman R, Lampert C, Diamond J, Kaye W (2000) Controlled family study of anorexia nervosa and bulimia nervosa: evidence of shared liability and transmission of partial syndromes. Am J Psychiatry 157:393–401PubMedCrossRefGoogle Scholar
  121. Strupp BJ, Weingartner H, Kaye W, Gwirtsman H (1986) Cognitive processing in anorexia nervosa. A disturbance in automatic information processing. Neuropsychobiology 15:89–94PubMedCrossRefGoogle Scholar
  122. Takenouchi K, Nishijo H, Uwano T, Tamura R, Takigawa M, Ono T (1999) Emotional and behavioral correlates of the anterior cingulate cortex during associative learning in rats. Neuroscience 93:1271–1287PubMedCrossRefGoogle Scholar
  123. Tauscher J, Pirker W, Willeit M, De Zwaan M, Bailer U, Neumeister A, Asenbaum S, Lennkh C, Praschak-Rieder N, Brücke T, Kasper S (2001) [123I]beta-CIT and single photon emission computed tomography reveal reduced brain serotonin transporter availability in bulimia nervosa. Biol Psychiatry 49:326–332PubMedCrossRefGoogle Scholar
  124. Tiihonen J, Keski-Rahkonen A, Lopponen M, Muhonen M, Kajander J, Allonen T, Nagren K, Hietala J, Rissanen A (2004) Brain serotonin 1A receptor binding in bulimia nervosa. Biol Psychiatry 55:871–873PubMedCrossRefGoogle Scholar
  125. Tollefson GD (1995) Selective serotonin reuptake inhibitors. In: Schatzberg AF, Nemeroff CB (eds) Textbook of psychopharmacology. American Psychiatric Press, Washington DC, USAGoogle Scholar
  126. Treasure J, Campbell I (1994) The case for biology in the aetiology of anorexia nervosa. Psychol Med 24:3–8PubMedCrossRefGoogle Scholar
  127. Tremblay P, Blier P (2006) Catecholaminergic strategies for the treatment of major depression. Curr Drug Targets 7:149–158PubMedCrossRefGoogle Scholar
  128. Tucker DM, Luu P, Pribram KH (1995) Social and emotional self-regulation. Ann NY Acad Sci 769:213–39PubMedCrossRefGoogle Scholar
  129. Vitousek K, Manke F (1994) Personality variables and disorders in anorexia nervosa and bulimia nervosa. J Abnorm Psychol 103:137–147PubMedCrossRefGoogle Scholar
  130. Vollenweider F, Vontobel P, Hell D, Leenders K (1999) 5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man–a PET study with [11C]raclopride. Neuropsychopharmacology 20:424–433PubMedCrossRefGoogle Scholar
  131. Wagner A, Ruf M, Braus DF, Schmidt MH (2003) Neuronal activity changes and body image distortion in anorexia nervosa. NeuroReport 14:2193–2197PubMedCrossRefGoogle Scholar
  132. Wagner A, Barbarich N, Frank G, Bailer U, Weissfeld L, Henry S, Achenbach S, Vogel V, Plotnicov K, Mcconaha C, Kaye W, Wonderlich S (2006) Personality traits after recovery from eating disorders: Do subtypes differ? Int J Eat Disord 39:276–284PubMedCrossRefGoogle Scholar
  133. Walsh BT (1991) Psychopharmacologic treatment of bulimia nervosa. J Clin Psychiatry 52(Suppl):34–38PubMedGoogle Scholar
  134. Walsh BT, Hadigan CM, Devlin MJ, Gladis M, Roose SP (1991) Long-term outcome of antidepressant treatment for bulimia nervosa. Am J Psychiatry 148:1206–1212PubMedGoogle Scholar
  135. Walsh B, Kaplan A, Attia E, Olmsted M, Parides M, Carter J, Pike K, Devlin M, Woodside B, Roberto C, Rocket W (2006) Fluoxetine after weight restoration in anorexia nervosa: a randomized controlled trial. JAMA 295:2605–2612PubMedCrossRefGoogle Scholar
  136. Walters EE, Kendler KS (1995) Anorexia nervosa and anorexic-like syndromes in a population-based female twin sample. Am J Psychiatry 152:64–71PubMedGoogle Scholar
  137. Ward A, Brown N, Lightman S, Campbell IC, Treasure J (1998) Neuroendocrine, appetitive and behavioural responses to d-fenfluramine in women recovered from anorexia nervosa. Br J Psychiatry 172:351–358PubMedCrossRefGoogle Scholar
  138. Westergaard G, Suomi S, Chavanne T, Houser L, Hurley A, Cleveland A, Snoy P, Higley J (2003) Physiological correlates of aggression and impulsivity in free-ranging female primates. Neuropsychopharmacology 28:1045–1055PubMedGoogle Scholar
  139. Winstanley CA, Theobald DE, Dalley JW, Robbins TW (2005) Interactions between serotonin and dopamine in the control of impulsive choice in rats: Therapeutic implications for impulse control disorders. Neuropschopharmacology 30:669–682Google Scholar
  140. Young SN, Gauthier S (1981) Effect of tryptophan administration on tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human lumbar and cisternal cerebrospinal fluid. J Neurol Neurosurg Psychiatry 44:323–327PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2010

Authors and Affiliations

  1. 1.Department of Psychiatry, Eating Disorder Treatment and Research ProgramUniversity of CaliforniaSan DiegoUSA
  2. 2.Department of Psychiatry and Psychotherapy, Division of Biological PsychiatryMedical University of ViennaViennaAustria

Personalised recommendations